Oak Associates LTD Exelixis, Inc. Transaction History
Oak Associates LTD
- $1.48 Billion
- Q3 2024
A detailed history of Oak Associates LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Oak Associates LTD holds 96,517 shares of EXEL stock, worth $3.17 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
96,517
Previous 121,517
20.57%
Holding current value
$3.17 Million
Previous $2.73 Million
8.28%
% of portfolio
0.17%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding EXEL
# of Institutions
509Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$964 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$835 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$505 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$376 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...